European consensus meeting/statement on Bronchial Thermoplasty Who? Where? How?

Robert Niven, Michel Aubier, Peter Bonta, Luis Puente-Maestu, Nicola Facciolongo, Dorothy Ryan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Bronchial Thermoplasty (BT) is a bronchoscopic treatment for severe asthma. Following research trials there remains a need to guide BT treatment in clinical practice, specifically in the fields of patient assessment, selection and positioning of BT within the range of treatment modalities, BT treatment protocols and post-BT management and follow-up. Consensus statements can bridge the gap between evidence-based medicine and real world clinical practice. Methods: We performed a modified RAND consensus analysis using a baseline list of statements derived from ATS/ERS Guidelines on Severe Asthma, Cochrane review and UK commissioning guidance. A panel of 5 European BT experts, individually scored the statements and following a day of discussion, rescored a revised final list independently. Results: An initial list of 132 statements, were independently scored. These were modified to 108 following group discussion. Consensus/total agreement was reached for 68 (63%) of the statements; 8 (7.4%) statements achieving total disagreement. For only 17 statements, could some form of consensus not be achieved. Conclusions: The consensus document could be applied to guide BT clinical practice and used to serve as a minimum acceptable level of assessment for BT, drive the development of clinical practice protocols and help define quality indicators

Original languageEnglish
Pages (from-to)161-164
Number of pages4
JournalRespiratory Medicine
Volume150
DOIs
Publication statusPublished - Apr 1 2019

Fingerprint

Clinical Protocols
Asthma
Patient Positioning
Evidence-Based Medicine
Patient Selection
Therapeutics
Guidelines
Research

Keywords

  • Asthma
  • Consensus
  • Thermoplasty

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

European consensus meeting/statement on Bronchial Thermoplasty Who? Where? How? / Niven, Robert; Aubier, Michel; Bonta, Peter; Puente-Maestu, Luis; Facciolongo, Nicola; Ryan, Dorothy.

In: Respiratory Medicine, Vol. 150, 01.04.2019, p. 161-164.

Research output: Contribution to journalArticle

Niven, Robert ; Aubier, Michel ; Bonta, Peter ; Puente-Maestu, Luis ; Facciolongo, Nicola ; Ryan, Dorothy. / European consensus meeting/statement on Bronchial Thermoplasty Who? Where? How?. In: Respiratory Medicine. 2019 ; Vol. 150. pp. 161-164.
@article{cf905786c3a743a2b82c7343f9f27eef,
title = "European consensus meeting/statement on Bronchial Thermoplasty Who? Where? How?",
abstract = "Background: Bronchial Thermoplasty (BT) is a bronchoscopic treatment for severe asthma. Following research trials there remains a need to guide BT treatment in clinical practice, specifically in the fields of patient assessment, selection and positioning of BT within the range of treatment modalities, BT treatment protocols and post-BT management and follow-up. Consensus statements can bridge the gap between evidence-based medicine and real world clinical practice. Methods: We performed a modified RAND consensus analysis using a baseline list of statements derived from ATS/ERS Guidelines on Severe Asthma, Cochrane review and UK commissioning guidance. A panel of 5 European BT experts, individually scored the statements and following a day of discussion, rescored a revised final list independently. Results: An initial list of 132 statements, were independently scored. These were modified to 108 following group discussion. Consensus/total agreement was reached for 68 (63{\%}) of the statements; 8 (7.4{\%}) statements achieving total disagreement. For only 17 statements, could some form of consensus not be achieved. Conclusions: The consensus document could be applied to guide BT clinical practice and used to serve as a minimum acceptable level of assessment for BT, drive the development of clinical practice protocols and help define quality indicators",
keywords = "Asthma, Consensus, Thermoplasty",
author = "Robert Niven and Michel Aubier and Peter Bonta and Luis Puente-Maestu and Nicola Facciolongo and Dorothy Ryan",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.rmed.2019.02.020",
language = "English",
volume = "150",
pages = "161--164",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - European consensus meeting/statement on Bronchial Thermoplasty Who? Where? How?

AU - Niven, Robert

AU - Aubier, Michel

AU - Bonta, Peter

AU - Puente-Maestu, Luis

AU - Facciolongo, Nicola

AU - Ryan, Dorothy

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Background: Bronchial Thermoplasty (BT) is a bronchoscopic treatment for severe asthma. Following research trials there remains a need to guide BT treatment in clinical practice, specifically in the fields of patient assessment, selection and positioning of BT within the range of treatment modalities, BT treatment protocols and post-BT management and follow-up. Consensus statements can bridge the gap between evidence-based medicine and real world clinical practice. Methods: We performed a modified RAND consensus analysis using a baseline list of statements derived from ATS/ERS Guidelines on Severe Asthma, Cochrane review and UK commissioning guidance. A panel of 5 European BT experts, individually scored the statements and following a day of discussion, rescored a revised final list independently. Results: An initial list of 132 statements, were independently scored. These were modified to 108 following group discussion. Consensus/total agreement was reached for 68 (63%) of the statements; 8 (7.4%) statements achieving total disagreement. For only 17 statements, could some form of consensus not be achieved. Conclusions: The consensus document could be applied to guide BT clinical practice and used to serve as a minimum acceptable level of assessment for BT, drive the development of clinical practice protocols and help define quality indicators

AB - Background: Bronchial Thermoplasty (BT) is a bronchoscopic treatment for severe asthma. Following research trials there remains a need to guide BT treatment in clinical practice, specifically in the fields of patient assessment, selection and positioning of BT within the range of treatment modalities, BT treatment protocols and post-BT management and follow-up. Consensus statements can bridge the gap between evidence-based medicine and real world clinical practice. Methods: We performed a modified RAND consensus analysis using a baseline list of statements derived from ATS/ERS Guidelines on Severe Asthma, Cochrane review and UK commissioning guidance. A panel of 5 European BT experts, individually scored the statements and following a day of discussion, rescored a revised final list independently. Results: An initial list of 132 statements, were independently scored. These were modified to 108 following group discussion. Consensus/total agreement was reached for 68 (63%) of the statements; 8 (7.4%) statements achieving total disagreement. For only 17 statements, could some form of consensus not be achieved. Conclusions: The consensus document could be applied to guide BT clinical practice and used to serve as a minimum acceptable level of assessment for BT, drive the development of clinical practice protocols and help define quality indicators

KW - Asthma

KW - Consensus

KW - Thermoplasty

UR - http://www.scopus.com/inward/record.url?scp=85063377610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063377610&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2019.02.020

DO - 10.1016/j.rmed.2019.02.020

M3 - Article

AN - SCOPUS:85063377610

VL - 150

SP - 161

EP - 164

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

ER -